SCHEMBL23217037

SCHEMBL23217037

CC(=O)N1CCc2cc(S(=O)(=O)N3CCCN(c4cccc(C(F)(F)F)c4)CCC3)ccc21

nearest known ligand 0.83

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.83
PTPN11 Q06124 5/20 0.68
KMT2A Q03164 1/20 0.63
PAX8 Q06710 1/20 0.63
TSHR P16473 2/20 0.61
HTT P42858 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
USP2 O75604 1/20 0.61
GAA P10253 1/20 0.61
PKM P14618 1/20 0.61
MAPT P10636 1/20 0.59
TNF P01375 2/20 0.59
NOD2 Q9HC29 2/20 0.59
NOD1 Q9Y239 2/20 0.59
TP53 P04637 2/20 0.58
POLB P06746 1/20 0.58
NOTUM Q6P988 1/20 0.55
MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217112 0.98 LMNA (0.86) LMNAPTPN11KMT2APAX8TSHR
SCHEMBL23228834 0.94 LMNA (0.89) LMNAPTPN11KMT2APAX8TSHR
SCHEMBL23217012 0.85 PTPN11 (0.75) LMNAPTPN11KMT2APAX8TSHR
SCHEMBL1470562 0.84 TNF (0.76) LMNAPTPN11SMN1; SMN2GAATNF
SCHEMBL12372368 0.83 PTPN11 (0.84) LMNAPTPN11POLB
SCHEMBL23217028 0.82 LMNA (0.70) LMNAPTPN11KMT2APAX8TSHR
SCHEMBL31055559 0.82 LMNA (0.70) LMNAPTPN11KMT2APAX8TSHR
SCHEMBL31055560 0.82 LMNA (0.70) LMNAPTPN11KMT2APAX8TSHR
SCHEMBL23228857 0.82 LMNA (0.70) LMNAPTPN11TNFNOD2NOD1
SCHEMBL23228858 0.82 LMNA (0.70) LMNAPTPN11KMT2APAX8TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2024-04-18 US disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME CFH, LPAR3, CBR3 LMNA 512/4885PTPN11 3165/4885KMT2A 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.